Market cap
$7,870 Mln
Revenue (TTM)
$1,362 Mln
P/E Ratio
34.3
P/B Ratio
3.9
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 5.99 | 7.19 | 7.58 | 14.09 | 12.94 |
| EBIT | 50.38 | 8.76 | 51.75 | 97.35 | 67.09 |
| Net Profit | 39.56 | 28.75 | 89.40 | 147.81 | 33.97 |
| EPS | -- | -- | -- | -- | -- |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Jan-26 | Jan-25 |
| EBIT-Margin
| 17.67 | 9.94 | 24.77 | 25.47 | 14.59 |
| Net Margin
| -- | -- | 17.36 | -- | -- |
| Return on equity
| 5.90 | 2.71 | 11.54 | 10.19 | 4.66 |
| Return on Capital
| 3.94 | 1.85 | -- | 6.80 | 3.12 |
| Return on Assets
| 3.65 | 1.72 | 6.80 | 6.26 | 2.92 |
| Debt to Equity (x)
| -- | -- | 0.47 | 0.48 | 0.52 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Jan-26
|
Jan-25
|
Jan-24
|
Jan-23
|
|---|---|---|---|---|---|
|
HealthEquity (HQY)
|
--
|
6.80
|
3.12
|
1.90
|
-0.91
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
11.54
Higher than Peers by 1.03
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Jan-26
|
Jan-25
|
Jan-24
|
Jan-23
|
|---|---|---|---|---|---|
|
HealthEquity (HQY)
|
11.54
|
10.19
|
4.66
|
2.83
|
-1.39
|
|
Peer Median
|
10.52
|
--
|
--
|
--
|
--
|
ROA
6.80
Higher than Peers by 3.31
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Jan-26
|
Jan-25
|
Jan-24
|
Jan-23
|
|---|---|---|---|---|---|
|
HealthEquity (HQY)
|
6.80
|
6.26
|
2.92
|
1.78
|
-0.84
|
|
Peer Median
|
3.49
|
--
|
--
|
--
|
--
|
EBIT Margin
24.77
Higher than Peers by 16.65
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Jan-26
|
Jan-25
|
Jan-24
|
Jan-23
|
|---|---|---|---|---|---|
|
HealthEquity (HQY)
|
24.77
|
25.47
|
14.59
|
12.94
|
1.20
|
|
Peer Median
|
8.12
|
--
|
--
|
--
|
--
|
Net Margin
17.36
Higher than Peers by 8.95
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Jan-26
|
Jan-25
|
Jan-24
|
Jan-23
|
|---|---|---|---|---|---|
|
HealthEquity (HQY)
|
17.36
|
16.38
|
8.06
|
5.57
|
-3.03
|
|
Peer Median
|
8.42
|
--
|
--
|
--
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Jan-26
|
Jan-25
|
Jan-24
|
Jan-23
|
|---|---|---|---|---|---|
|
HealthEquity (HQY)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
7.34
Lower than Peers by 8.52
Year on year growth in net sales
|
Company Name
|
TTM
|
Jan-26
|
Jan-25
|
Jan-24
|
Jan-23
|
|---|---|---|---|---|---|
|
HealthEquity (HQY)
|
7.34
|
0.09
|
0.20
|
0.16
|
0.14
|
|
Peer Median
|
15.86
|
--
|
--
|
--
|
--
|
EBIT Growth
35.84
Higher than Peers by 5.31
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Jan-26
|
Jan-25
|
Jan-24
|
Jan-23
|
|---|---|---|---|---|---|
|
HealthEquity (HQY)
|
35.84
|
91.08
|
35.38
|
1,152.30
|
130.18
|
|
Peer Median
|
30.53
|
--
|
--
|
--
|
--
|
Net Profit Growth
89.40
Higher than Peers by 58.24
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Jan-26
|
Jan-25
|
Jan-24
|
Jan-23
|
|---|---|---|---|---|---|
|
HealthEquity (HQY)
|
89.40
|
122.54
|
73.58
|
313.10
|
40.97
|
|
Peer Median
|
31.16
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.47
--
Total debt / Net worth
|
Company Name
|
TTM
|
Jan-26
|
Jan-25
|
Jan-24
|
Jan-23
|
|---|---|---|---|---|---|
|
HealthEquity (HQY)
|
0.47
|
0.48
|
0.52
|
0.46
|
0.52
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.01
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Jan-26
|
Jan-25
|
Jan-24
|
Jan-23
|
|---|---|---|---|---|---|
|
HealthEquity (HQY)
|
0.01
|
0.00
|
0.00
|
0.00
|
0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.99
Higher than Peers by 1.41
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Jan-26
|
Jan-25
|
Jan-24
|
Jan-23
|
|---|---|---|---|---|---|
|
HealthEquity (HQY)
|
2.99
|
3.27
|
3.06
|
4.76
|
2.92
|
|
Peer Median
|
1.58
|
--
|
--
|
--
|
--
|
Quick Ratio
2.99
Higher than Peers by 1.43
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Jan-26
|
Jan-25
|
Jan-24
|
Jan-23
|
|---|---|---|---|---|---|
|
HealthEquity (HQY)
|
2.99
|
--
|
--
|
--
|
2.92
|
|
Peer Median
|
1.56
|
--
|
--
|
--
|
--
|
Interest Coverage
6.88
Lower than Peers by 7.26
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Jan-26
|
Jan-25
|
Jan-24
|
Jan-23
|
|---|---|---|---|---|---|
|
HealthEquity (HQY)
|
6.88
|
5.86
|
2.89
|
2.33
|
0.21
|
|
Peer Median
|
14.14
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
8.97
Lower than Peers by 9.44
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Jan-26
|
Jan-25
|
Jan-24
|
Jan-23
|
|---|---|---|---|---|---|
|
HealthEquity (HQY)
|
8.97
|
9.42
|
9.84
|
10.49
|
11.24
|
|
Peer Median
|
18.41
|
--
|
--
|
--
|
--
|
Asset Turnover
0.39
Lower than Peers by 0.05
Sales / Average Total Assets
|
Company Name
|
TTM
|
Jan-26
|
Jan-25
|
Jan-24
|
Jan-23
|
|---|---|---|---|---|---|
|
HealthEquity (HQY)
|
0.39
|
0.38
|
0.36
|
0.32
|
0.28
|
|
Peer Median
|
0.44
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Jan-26
|
Jan-25
|
Jan-24
|
Jan-23
|
|---|---|---|---|---|---|
|
HealthEquity (HQY)
|
--
|
33.61
|
33.93
|
36.86
|
39.05
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Jan-26
|
Jan-25
|
Jan-24
|
Jan-23
|
|---|---|---|---|---|---|
|
HealthEquity (HQY)
|
--
|
--
|
--
|
0.00
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Jan-26
|
Jan-25
|
Jan-24
|
Jan-23
|
|---|---|---|---|---|---|
|
HealthEquity (HQY)
|
--
|
12.10
|
9.51
|
10.09
|
16.23
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Jan-26
|
Jan-25
|
Jan-24
|
Jan-23
|
|---|---|---|---|---|---|
|
HealthEquity (HQY)
|
--
|
--
|
--
|
26.77
|
22.82
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
34.35
Lower than Peers by 21.56
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Jan-26
|
Jan-25
|
Jan-24
|
Jan-23
|
|---|---|---|---|---|---|
|
HealthEquity (HQY)
|
34.35
|
--
|
--
|
--
|
--
|
|
Peer Median
|
55.91
|
--
|
--
|
--
|
--
|
Price / Book Value
3.93
Lower than Peers by 4.43
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Jan-26
|
Jan-25
|
Jan-24
|
Jan-23
|
|---|---|---|---|---|---|
|
HealthEquity (HQY)
|
3.93
|
--
|
--
|
--
|
--
|
|
Peer Median
|
8.35
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Jan-26
|
Jan-25
|
Jan-24
|
Jan-23
|
|---|---|---|---|---|---|
|
HealthEquity (HQY)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
16.44
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Jan-26
|
Jan-25
|
Jan-24
|
Jan-23
|
|---|---|---|---|---|---|
|
HealthEquity (HQY)
|
16.44
|
1.40
|
2.41
|
1.87
|
4.32
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
7,870
Higher than Peers by 6,731
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Jan-26
|
Jan-25
|
Jan-24
|
Jan-23
|
|---|---|---|---|---|---|
|
HealthEquity (HQY)
|
7,870
|
--
|
--
|
--
|
--
|
|
Peer Median
|
1,138
|
--
|
--
|
--
|
--
|